Quick Takeaways
- HIGHBRIDGE CAPITAL MANAGEMENT LLC filed SCHEDULE 13G for Inovio Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (INO).
- Disclosed ownership: 9.2%.
- Date of event: 31 Dec 2024.
HIGHBRIDGE CAPITAL MANAGEMENT LLC - 31 Dec 2024 SCHEDULE 13G Report for Inovio Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (INO)
- Filing Manager
- HIGHBRIDGE CAPITAL MANAGEMENT LLC
- Reporting Manager
- Highbridge Capital Management, LLC
- Symbol
- INO
- Shares outstanding
- 39,492,750 shares
- Disclosed Ownership
- 3,633,333 shares
- Ownership
- 9.2%
- Form type
- SCHEDULE 13G
- Filing time
- 10 Feb 2025, 17:06:11 UTC
- Date of event
- 31 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"HIGHBRIDGE CAPITAL MANAGEMENT LLC disclosed 9.2% ownership in Inovio Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (INO) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 10 Feb 2025, 17:06.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Highbridge Capital Management, LLC | 9.2% | 3,633,333 | 0 | 3,633,333 | /s/ Kirk Rule | Kirk Rule, Executive Director |